L
Lanmei Chen
Researcher at Murdoch University
Publications - 10
Citations - 559
Lanmei Chen is an academic researcher from Murdoch University. The author has contributed to research in topics: DNA damage & Apoptosis. The author has an hindex of 5, co-authored 10 publications receiving 206 citations.
Papers
More filters
Journal ArticleDOI
Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.
Dongbin Yang,Weihong Zhang,Huanyun Zhang,Fengqiu Zhang,Lanmei Chen,Lixia Ma,Leon M Larcher,Suxiang Chen,Nan Liu,Qingxia Zhao,Phuong H.L. Tran,Changying Chen,Rakesh N. Veedu,Tao Wang,Tao Wang +14 more
TL;DR: A panoramic view of current exosome isolation techniques is provided, providing perspectives toward the development of novel approaches for high-efficient exosomes isolation from various types of biological matrices.
Journal ArticleDOI
Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
TL;DR: Antitumor mechanism studies show that Ru1 and Ru2 can cause cell cycle arrest in the G0/G1 phase by regulating cell cycle relative proteins and induce apoptosis through mitochondrial dysfunction, reactive oxygen species (ROS) accumulation and ROS-mediated DNA damage.
Journal ArticleDOI
Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.
Tao Wang,Lanmei Chen,Arpitha Chikkanna,Suxiang Chen,Isabell Brusius,Nabayet Sbuh,Rakesh N. Veedu +6 more
TL;DR: In this paper, a comprehensive overview of aptamer-based lateral flow assay (LFA) design strategies is provided to facilitate researchers to develop optimised aptamerbased LFAs, including immobilization strategies, signalling methods, and target capturing approaches.
Journal ArticleDOI
Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Jincan Chen,Yao Zhang,Xinming Jie,Ji She,Guang-zhi Dongye,Yu Zhong,Yuanyuan Deng,Jie Wang,Bo-yang Guo,Lanmei Chen +9 more
TL;DR: Three Ru(II) complexes with salicylate as ligand were synthesized and characterized and the anticancer effect exerted by them was evaluated, found to exhibit obvious anticancer activity, in comparison with cisplatin, against cancer cell lines, while displaying low toxicity to the normal cell line BEAS-2B.
Journal ArticleDOI
Cytotoxicity in vitro, cellular uptake, localization and apoptotic mechanism studies induced by ruthenium(II) complex.
Jincan Chen,Yao Zhang,Guo-dong Li,Fa Peng,Xinming Jie,Ji She,Guang-zhi Dongye,Zhilin Zou,Rong Shiwen,Lanmei Chen +9 more
TL;DR: The results showed that ruthenium (II) methylimidazole complexes exhibited moderate antitumor activity comparable with cisplatin against A549, NCI-H460, MCF-7 and HepG2 human cancer cells, but with less toxicity to a human normal cell line HBE.